Evidence map›Paper›PMID 30251217›Full record

ArticleInflammation2019

Chronic Inflammation Contributes to Tumor Growth: Possible Role of L-Selectin-Expressing Myeloid-Derived Suppressor Cells (MDSCs).

Yuliya V Perfilyeva, Nurshat Abdolla, Yekaterina O Ostapchuk, Raikhan Tleulieva, Vladimir C Krasnoshtanov, Anastassiya V Perfilyeva, Nikolai N Belyaev

Abstract read
PubMed Publisher
In one paragraph

Article in Inflammation, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
0.9field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 20 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 3 countries.

Yuliya V PerfilyevaLaboratory of Molecular Immunology and Immunobiotechnology, M.A. Aitkhozhin's Institute of Molecular Biology and Biochemistry, Almaty, Kazakhstan. perfilyevayulya@gmail.com.ORCID http://orcid.org/0000-0001-6803-0773
Nurshat AbdollaLaboratory of Molecular Immunology and Immunobiotechnology, M.A. Aitkhozhin's Institute of Molecular Biology and Biochemistry, Almaty, Kazakhstan.
Yekaterina O OstapchukLaboratory of Molecular Immunology and Immunobiotechnology, M.A. Aitkhozhin's Institute of Molecular Biology and Biochemistry, Almaty, Kazakhstan.
Raikhan TleulievaLaboratory of Molecular Immunology and Immunobiotechnology, M.A. Aitkhozhin's Institute of Molecular Biology and Biochemistry, Almaty, Kazakhstan.
Vladimir C KrasnoshtanovKazakh Research Institute of Oncology & Radiology, Almaty, Kazakhstan.
Anastassiya V PerfilyevaInstitute of General Genetics and Cytology, Laboratory of Molecular Genetics, Almaty, Kazakhstan.
Nikolai N BelyaevSaint-Petersburg Pasteur Institute, Saint-Petersburg, Russia.
Institute of Plant Biology and Biotechnology · KZKazakh Institute of Oncology and Radiology · KZAl-Farabi Kazakh National University · KZSaint Petersburg Pasteur Institute · RU

Funding

Committee of Science of Ministry of Education and Science of the Republic of Kazakhstan AP05131710
6 · The paper itself

Abstract

Recent data have demonstrated that chronic inflammation is a crucial component of tumor initiation and progression. We previously reported that immature myeloid-derived suppressor cells (MDSCs) with immunosuppressive activity toward effector T cells were expanded in experimental chronic inflammation. We hypothesized that elevated levels of MDSCs, induced by chronic inflammation, may contribute to the progression of tumor growth. Using the Ehrlich carcinoma animal model, we found increased tumor growth in mice with chronic adjuvant arthritis, which was accompanied by a persistent increase in the proportion of splenic monocytic and granulocytic MDSCs expressing CD62L (L-selectin), when compared to tumor mice without adjuvant arthritis. Depletion of inflammation-induced MDSCs resulted in decreased tumor growth. In vitro studies demonstrated that increased expression of CD62L by MDSCs was mediated by TNFα, elevated concentrations of which were found in tumor mice subjected to chronic inflammation. Moreover, the addition of exogenous TNFα markedly enhanced the suppressive activity of bone marrow-derived MDSCs, as revealed by the ability to impair the proliferation of CD8

Indexed as

Tumor BurdenAnimalsArthritis, ExperimentalCell MovementChronic DiseaseInflammationL-SelectinMiceMyeloid-Derived Suppressor CellsTumor Necrosis Factor-alphaL-SelectinTumor Necrosis Factor-alphacancerchronic inflammationG-MDSCL-selectinM-MDSCTNFα

Identifiers

PMID30251217
OpenAlexW2893938675

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.